Celsius (NASDAQ:CELH) Rating Increased to Buy at TD Cowen

TD Cowen upgraded shares of Celsius (NASDAQ:CELH) from a hold rating to a buy rating in a report released on Monday, MarketBeat reports. The firm currently has $55.00 price target on the stock, up from their prior price target of $37.00.

CELH has been the topic of a number of other reports. Stifel Nicolaus assumed coverage on shares of Celsius in a research report on Thursday, June 12th. They set a “buy” rating and a $47.00 price target on the stock. Piper Sandler increased their price target on shares of Celsius from $44.00 to $45.00 and gave the company an “overweight” rating in a research report on Wednesday, June 4th. UBS Group increased their price target on shares of Celsius from $43.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, April 17th. Needham & Company LLC reiterated a “buy” rating and set a $47.00 price target on shares of Celsius in a research report on Thursday, May 29th. Finally, Truist Financial increased their price target on shares of Celsius from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Friday, June 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Celsius presently has a consensus rating of “Moderate Buy” and a consensus target price of $47.24.

Celsius Trading Up 5.7%

CELH stock opened at $43.49 on Monday. The company’s 50 day moving average is $37.45 and its 200 day moving average is $31.34. The stock has a market cap of $11.21 billion, a price-to-earnings ratio of 98.84, a price-to-earnings-growth ratio of 2.90 and a beta of 1.43. Celsius has a 1-year low of $21.10 and a 1-year high of $64.19.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). Celsius had a return on equity of 51.89% and a net margin of 10.70%. The company had revenue of $329.28 million during the quarter, compared to the consensus estimate of $349.09 million. During the same quarter last year, the company posted $0.27 earnings per share. The firm’s revenue for the quarter was down 7.4% on a year-over-year basis. As a group, sell-side analysts forecast that Celsius will post 0.89 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO John Fieldly sold 132,171 shares of the firm’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $43.06, for a total value of $5,691,283.26. Following the completion of the sale, the chief executive officer now owns 1,169,380 shares of the company’s stock, valued at $50,353,502.80. This trade represents a 10.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.55% of the stock is currently owned by insiders.

Institutional Trading of Celsius

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geneos Wealth Management Inc. lifted its position in Celsius by 30.4% during the first quarter. Geneos Wealth Management Inc. now owns 26,804 shares of the company’s stock valued at $955,000 after buying an additional 6,250 shares during the period. Bayforest Capital Ltd purchased a new position in Celsius during the first quarter valued at $647,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Celsius by 14.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 433,241 shares of the company’s stock valued at $15,432,000 after buying an additional 53,844 shares during the period. United Services Automobile Association purchased a new position in Celsius during the first quarter valued at $334,000. Finally, Meiji Yasuda Asset Management Co Ltd. purchased a new position in Celsius during the first quarter valued at $254,000. Hedge funds and other institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.